Page last updated: 2024-11-05

tranexamic acid and ACTH-Producing Pituitary Adenoma

tranexamic acid has been researched along with ACTH-Producing Pituitary Adenoma in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid (TXA) is a well-studied, widely used intravenous hemostatic; however, the potential benefit during resection of ACTH-secreting pituitary adenoma is unstudied."7.01Perioperative Tranexamic Acid for ACTH-Secreting Pituitary Adenomas: Implementation Protocol Results and Trial Prospectus. ( Carlstrom, LP; Choby, G; Cohen, SC; Graffeo, CS; Perry, A; Van Gompel, JJ, 2021)
"Tranexamic acid (TXA) is a well-studied, widely used intravenous hemostatic; however, the potential benefit during resection of ACTH-secreting pituitary adenoma is unstudied."3.01Perioperative Tranexamic Acid for ACTH-Secreting Pituitary Adenomas: Implementation Protocol Results and Trial Prospectus. ( Carlstrom, LP; Choby, G; Cohen, SC; Graffeo, CS; Perry, A; Van Gompel, JJ, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Graffeo, CS1
Carlstrom, LP1
Cohen, SC1
Perry, A1
Choby, G1
Van Gompel, JJ1

Trials

1 trial available for tranexamic acid and ACTH-Producing Pituitary Adenoma

ArticleYear
Perioperative Tranexamic Acid for ACTH-Secreting Pituitary Adenomas: Implementation Protocol Results and Trial Prospectus.
    World neurosurgery, 2021, Volume: 153

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antifibrinolytic Agents; Hemorrhage; Humans; Intraoperati

2021